Annette Deichmann

Author PubWeight™ 23.96^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1.	Nat Med	2006	9.68
2	Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo.	J Clin Invest	2007	2.80
3	Comprehensive genomic access to vector integration in clinical gene therapy.	Nat Med	2009	2.19
4	Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis.	Blood	2005	1.82
5	Bioinformatic clonality analysis of next-generation sequencing-derived viral vector integration sites.	Hum Gene Ther Methods	2012	1.21
6	Mutations in ROGDI Cause Kohlschütter-Tönz Syndrome.	Am J Hum Genet	2012	1.21
7	Real-time definition of non-randomness in the distribution of genomic events.	PLoS One	2007	1.14
8	Analyzing the number of common integration sites of viral vectors--new methods and computer programs.	PLoS One	2011	1.10
9	Parallel assessment of globin lentiviral transfer in induced pluripotent stem cells and adult hematopoietic stem cells derived from the same transplanted β-thalassemia patient.	Stem Cells	2013	1.01
10	Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell disease.	Curr Gene Ther	2015	0.89
11	Biosafety considerations using gamma-retroviral vectors in gene therapy.	Curr Gene Ther	2013	0.83
12	Vector integration and tumorigenesis.	Hum Gene Ther	2014	0.75